Colgate-Palmolive Company (CL) 10-Year Financial Performance & Capital Metrics

CL •

Consumer DefensiveHousehold ProductsPersonal Care and Beauty Products

AboutColgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.Show more

Revenue $20.38B +1.4%
EBITDA $4.98B -0.2%
Net Income $2.13B -26.2%
EPS (Diluted) 2.63 -25.1%
Gross Margin 60.11% -0.2%
EBITDA Margin 24.42% -1.6%
Operating Margin 21.33% -2.2%
Net Margin 10.46% -27.2%
ROE 469.09% +21.9%
ROIC 43.41% +12.3%
Debt/Equity 21.88 +39.9%
Interest Coverage 16.28 +8.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 371.6%
✓FCF machine: 17.8% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 2.3%
✓Healthy 5Y average net margin of 11.8%
✓Trading near 52-week high

✗Weaknesses

✗High debt to equity ratio of 21.9x
✗Expensive at 220.3x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.43%

5Y4.35%

3Y4.29%

TTM1.4%

Profit (Net Income) CAGR

10Y4.42%

5Y-4.58%

3Y6.1%

TTM-26.26%

EPS CAGR

10Y5.64%

5Y-3.48%

3Y7.28%

TTM-25.45%

ROCE

10Y Avg38.86%

5Y Avg36.61%

3Y Avg38.98%

Latest41.65%

Peer Comparison

Personal Care and Beauty Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
DSYBig Tree Cloud Holdings Limited	178.66M	3.13	254.47	16.37%	-4.42%	2.43%
AXILAXIL Brands, Inc.	46.22M	6.80	67.95	-4.51%	4.95%	12.37%	3.32%	0.08
ELFe.l.f. Beauty, Inc.	5.13B	92.05	47.94	28.28%	6.84%	8.95%	2.25%	0.41
EPCEdgewell Personal Care Company	1.06B	22.74	42.91	-1.34%	-1.76%	-2.57%	3.9%	0.99
CLColgate-Palmolive Company	79.91B	99.14	37.70	1.4%	10.46%	5.84%	4.55%	21.88
IPARInter Parfums, Inc.	3.23B	100.78	19.68	10.22%	11.24%	14.9%	5.66%	0.20
SLSNSolesence, Inc. Common Stock	90.29M	1.28	18.29	40.35%	1.72%	6.21%		1.02
COTYCoty Inc.	2.19B	2.51	-5.70	-3.68%	-9.19%	-14.39%	12.68%	1.07

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	15.2B	15.45B	15.54B	15.69B	16.47B	17.42B	17.97B	19.46B	20.1B	20.38B
Revenue Growth %	-5.23%	1.7%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%	1.4%
Cost of Goods Sold+	6.06B	6.13B	6.34B	6.42B	6.54B	7.13B	7.82B	8.21B	8B	8.13B
COGS % of Revenue	39.9%	39.67%	40.77%	40.88%	39.69%	40.92%	43.51%	42.18%	39.77%	39.89%
Gross Profit+	9.13B	9.32B	9.21B	9.28B	9.93B	10.29B	10.15B	11.25B	12.11B	12.25B
Gross Margin %	60.1%	60.33%	59.23%	59.12%	60.31%	59.08%	56.49%	57.82%	60.23%	60.11%
Gross Profit Growth %	-2.54%	2.09%	-1.26%	0.77%	7.07%	3.62%	-1.39%	10.85%	7.6%	1.2%
Operating Expenses+	5.17B	5.31B	5.36B	5.51B	6.02B	6.41B	6.57B	7.12B	7.72B	7.9B
OpEx % of Revenue	34.04%	34.39%	34.46%	35.14%	36.56%	36.78%	36.54%	36.59%	38.42%	38.77%
Selling, General & Admin	4.88B	5.03B	5.08B	5.23B	5.73B	6.1B	6.25B	6.78B	7.81B	7.9B
SG&A % of Revenue	32.14%	32.54%	32.67%	33.35%	34.8%	35.02%	34.76%	34.83%	38.85%	38.77%
Research & Development	289M	285M	277M	281M	290M	307M	320M	343M	355M	0
R&D % of Revenue	1.9%	1.84%	1.78%	1.79%	1.76%	1.76%	1.78%	1.76%	1.77%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	-442M	0
Operating Income+	3.96B	4.01B	3.85B	3.76B	3.91B	3.89B	3.58B	4.13B	4.38B	4.35B
Operating Margin %	26.06%	25.94%	24.77%	23.97%	23.74%	22.31%	19.95%	21.23%	21.8%	21.33%
Operating Income Growth %	-0.25%	1.24%	-3.97%	-2.29%	3.96%	-0.64%	-7.75%	15.23%	6.1%	-0.8%
EBITDA+	4.4B	4.48B	4.36B	4.28B	4.45B	4.44B	4.13B	4.7B	4.99B	4.98B
EBITDA Margin %	28.98%	29.02%	28.06%	27.28%	27.02%	25.5%	22.99%	24.15%	24.81%	24.42%
EBITDA Growth %	-0.36%	1.84%	-2.74%	-1.83%	3.95%	-0.18%	-7.02%	13.75%	6.17%	-0.2%
D&A (Non-Cash Add-back)	443M	475M	511M	519M	539M	556M	545M	567M	605M	630M
EBIT	3.89B	3.64B	3.66B	3.49B	3.81B	3.2B	2.83B	3.68B	4.25B	3.33B
Net Interest Income+	-99M	-102M	-143M	-145M	-141M	-100M	-153M	-232M	-225M	-192M
Interest Income	50M	51M	50M	47M	19M	17M	14M	55M	67M	75M
Interest Expense	149M	153M	193M	192M	160M	117M	167M	287M	292M	267M
Other Income/Expense	-222M	-522M	-386M	-461M	-264M	-799M	-925M	-739M	-427M	-1.29B
Pretax Income+	3.74B	3.49B	3.46B	3.3B	3.65B	3.09B	2.66B	3.39B	3.96B	3.06B
Pretax Margin %	24.6%	22.56%	22.29%	21.03%	22.14%	17.72%	14.8%	17.43%	19.68%	15.01%
Income Tax+	1.15B	1.31B	906M	774M	787M	749M	693M	937M	907M	798M
Effective Tax Rate %	65.3%	58.04%	69.28%	71.71%	73.9%	70.17%	67.11%	67.81%	73.03%	69.7%
Net Income+	2.44B	2.02B	2.4B	2.37B	2.69B	2.17B	1.78B	2.3B	2.89B	2.13B
Net Margin %	16.06%	13.1%	15.44%	15.08%	16.36%	12.43%	9.93%	11.82%	14.37%	10.46%
Net Income Growth %	76.37%	-17.08%	18.58%	-1.38%	13.86%	-19.63%	-17.59%	28.85%	25.61%	-26.2%
Net Income (Continuing)	2.59B	2.17B	2.56B	2.53B	2.86B	2.34B	1.97B	2.46B	3.05B	2.26B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	260M	303M	299M	441M	358M	362M	405M	348M	332M	311M
EPS (Diluted)+	2.72	2.28	2.75	2.75	3.14	2.55	2.13	2.77	3.51	2.63
EPS Growth %	78.95%	-16.18%	20.61%	0%	14.18%	-18.79%	-16.47%	30.05%	26.71%	-25.07%
EPS (Basic)	2.74	2.30	2.76	2.76	3.15	2.56	2.13	2.78	3.53	2.64
Diluted Shares Outstanding	898.4M	887.8M	873M	861.1M	859.3M	848.3M	838.8M	829.2M	822.5M	811.1M
Basic Shares Outstanding	891.8M	881.8M	870.6M	859.1M	856.8M	845M	836.4M	827.4M	817.7M	808.7M
Dividend Payout Ratio	61.78%	75.54%	66.29%	68.19%	55.73%	77.52%	94.73%	76.04%	61.92%	85.51%

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	4.34B	4.64B	3.79B	4.18B	4.34B	4.4B	5.11B	5.28B	5.32B	5.71B
Cash & Short-Term Investments	1.31B	1.53B	726M	883M	888M	832M	775M	966M	1.26B	1.29B
Cash Only	1.31B	1.53B	726M	883M	888M	832M	775M	966M	1.1B	1.29B
Short-Term Investments	0	0	0	0	0	0	0	0	160M	0
Accounts Receivable	1.41B	1.48B	1.4B	1.44B	1.26B	1.3B	1.5B	1.59B	1.52B	1.68B
Days Sales Outstanding	33.89	34.96	32.87	33.49	28.01	27.17	30.55	29.75	27.62	30
Inventory	1.17B	1.22B	1.25B	1.4B	1.67B	1.69B	2.07B	1.93B	1.99B	2.03B
Days Inventory Outstanding	70.5	72.69	71.99	79.64	93.4	86.64	96.84	86.02	90.71	91.22
Other Current Assets	441M	403M	417M	456M	513M	576M	760M	793M	553M	714M
Total Non-Current Assets+	7.79B	8.04B	8.37B	10.86B	11.58B	10.64B	10.62B	11.11B	10.73B	10.62B
Property, Plant & Equipment	3.84B	4.07B	3.88B	3.75B	3.72B	3.73B	4.31B	4.58B	4.42B	4.66B
Fixed Asset Turnover	3.96x	3.80x	4.01x	4.18x	4.43x	4.67x	4.17x	4.25x	4.55x	4.37x
Goodwill	2.11B	2.22B	2.53B	3.51B	3.82B	3.28B	3.35B	3.41B	3.27B	3.12B
Intangible Assets	1.31B	1.34B	1.64B	2.67B	2.89B	2.46B	1.92B	1.89B	1.76B	1.54B
Long-Term Investments	0	0	0	0	0	0	0	0	81M	0
Other Non-Current Assets	224M	218M	168M	753M	857M	974M	904M	1.02B	1B	1.3B
Total Assets+	12.12B	12.68B	12.16B	15.03B	15.92B	15.04B	15.73B	16.39B	16.05B	16.33B
Asset Turnover	1.25x	1.22x	1.28x	1.04x	1.03x	1.16x	1.14x	1.19x	1.25x	1.25x
Asset Growth %	1.38%	4.56%	-4.06%	23.62%	5.89%	-5.53%	4.59%	4.21%	-2.12%	1.77%
Total Current Liabilities+	3.31B	3.41B	3.34B	4.04B	4.4B	4.05B	4B	4.74B	5.76B	5.74B
Accounts Payable	1.12B	1.21B	1.22B	1.24B	1.39B	1.48B	1.55B	1.7B	1.8B	0
Days Payables Outstanding	67.67	72.15	70.37	70.37	77.77	75.73	72.42	75.53	82.4	-
Short-Term Debt	13M	11M	12M	514M	267M	51M	25M	330M	660M	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	84M	101M	93M	70M	182M	93M	97M	122M	116M	5.74B
Current Ratio	1.31x	1.36x	1.14x	1.03x	0.99x	1.09x	1.28x	1.11x	0.92x	1.00x
Quick Ratio	0.96x	1.00x	0.76x	0.69x	0.61x	0.67x	0.76x	0.71x	0.58x	0.64x
Cash Conversion Cycle	36.72	35.49	34.49	42.77	43.64	38.08	54.97	40.25	35.93	-
Total Non-Current Liabilities+	8.8B	9.03B	8.62B	10.44B	10.41B	10.02B	10.92B	10.7B	9.74B	10.23B
Long-Term Debt	6.52B	6.57B	6.35B	7.33B	7.33B	7.19B	8.74B	8.22B	7.29B	7.99B
Capital Lease Obligations	0	0	0	491M	476M	451M	397M	420M	456M	0
Deferred Tax Liabilities	246M	204M	235M	507M	426M	395M	383M	361M	343M	0
Other Non-Current Liabilities	2.04B	2.25B	2.03B	2.11B	2.18B	1.98B	1.4B	1.7B	1.66B	2.24B
Total Liabilities	12.11B	12.43B	11.96B	14.48B	14.82B	14.07B	14.93B	15.44B	15.5B	15.96B
Total Debt+	6.53B	6.58B	6.37B	8.48B	8.21B	7.83B	9.27B	9.06B	8.51B	7.99B
Net Debt	5.22B	5.04B	5.64B	7.6B	7.33B	7B	8.5B	8.1B	7.42B	6.7B
Debt / Equity	384.29x	27.07x	32.31x	15.20x	7.46x	8.07x	11.50x	9.47x	15.65x	21.88x
Debt / EBITDA	1.48x	1.47x	1.46x	1.98x	1.85x	1.76x	2.24x	1.93x	1.71x	1.60x
Net Debt / EBITDA	1.19x	1.12x	1.29x	1.78x	1.65x	1.58x	2.06x	1.72x	1.49x	1.35x
Interest Coverage	26.58x	26.20x	19.95x	19.59x	24.44x	33.21x	21.47x	14.39x	15.01x	16.28x
Total Equity+	17M	243M	197M	558M	1.1B	971M	806M	957M	544M	365M
Equity Growth %	138.64%	1329.41%	-18.93%	183.25%	97.31%	-11.81%	-16.99%	18.73%	-43.16%	-32.9%
Book Value per Share	0.02	0.27	0.23	0.65	1.28	1.14	0.96	1.15	0.66	0.45
Total Shareholders' Equity	-243M	-60M	-102M	117M	743M	609M	401M	609M	212M	54M
Common Stock	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	0
Retained Earnings	19.92B	20.53B	21.61B	22.5B	23.7B	24.35B	24.57B	25.29B	26.14B	0
Treasury Stock	-19.14B	-20.18B	-21.2B	-22.06B	-23.05B	-24.09B	-25.13B	-26.02B	-27.36B	0
Accumulated OCI	-4.18B	-3.85B	-4.19B	-4.27B	-4.34B	-4.39B	-4.05B	-3.94B	-4.22B	0
Minority Interest	260M	303M	299M	441M	358M	362M	405M	348M	332M	311M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	3.14B	3.05B	3.06B	3.13B	3.72B	3.33B	2.56B	3.75B	4.11B	4.2B
Operating CF Margin %	20.67%	19.76%	19.66%	19.96%	22.58%	19.09%	14.23%	19.25%	20.43%	20.6%
Operating CF Growth %	6.51%	-2.77%	0.07%	2.52%	18.7%	-10.59%	-23.13%	46.52%	9.67%	2.22%
Net Income	2.59B	2.17B	2.56B	2.53B	2.86B	2.34B	1.97B	2.46B	3.05B	2.13B
Depreciation & Amortization	443M	475M	511M	519M	539M	556M	545M	567M	605M	630M
Stock-Based Compensation	123M	127M	109M	100M	107M	135M	125M	122M	135M	0
Deferred Taxes	56M	383M	107M	17M	-120M	-132M	-78M	-98M	-77M	-109M
Other Non-Cash Items	-159M	10M	-74M	-95M	-48M	625M	723M	244M	51M	1.26B
Working Capital Changes	92M	-115M	-155M	65M	381M	-197M	-726M	455M	344M	284M
Change in Receivables	-17M	-15M	-79M	19M	138M	-84M	-227M	-37M	-56M	-16M
Change in Inventory	-4M	-8M	-58M	-77M	-251M	-72M	-333M	194M	-100M	109M
Change in Payables	0	0	0	0	0	0	0	0	516M	251M
Cash from Investing+	-499M	-471M	-1.17B	-2.1B	-878M	-592M	-1.6B	-742M	-534M	-817M
Capital Expenditures	-593M	-553M	-436M	-335M	-410M	-567M	-696M	-705M	-561M	-564M
CapEx % of Revenue	3.9%	3.58%	2.8%	2.13%	2.49%	3.25%	3.87%	3.62%	2.79%	2.77%
Acquisitions	-5M	0	-728M	-1.71B	-452M	0	-809M	0	0	-293M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	57M	38M	7M	0	3M	-25M	52M	-33M	37M	-14M
Cash from Financing+	-2.23B	-2.45B	-2.68B	-870M	-2.82B	-2.77B	-952M	-2.79B	-3.39B	-3.26B
Debt Issued (Net)	164M	-29M	-179M	1.43B	-564M	-175M	1.65B	-314M	-408M	-456M
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Dividends Paid	-1.51B	-1.53B	-1.59B	-1.61B	-1.5B	-1.68B	-1.69B	-1.75B	-1.79B	-1.82B
Share Repurchases	-1.33B	-1.4B	-1.24B	-1.2B	-1.48B	-1.32B	-1.31B	-1.13B	-1.74B	-1.21B
Other Financing	446M	507M	329M	513M	-152M	400M	400M	398M	547M	132M
Net Change in Cash	345M	220M	-809M	157M	5M	-56M	-57M	191M	130M	192M
Free Cash Flow+	2.55B	2.5B	2.62B	2.8B	3.31B	2.76B	1.86B	3.04B	3.55B	3.63B
FCF Margin %	16.77%	16.18%	16.86%	17.83%	20.09%	15.83%	10.35%	15.62%	17.64%	17.83%
FCF Growth %	12.84%	-1.84%	4.76%	6.79%	18.26%	-16.65%	-32.56%	63.44%	16.64%	2.48%
FCF per Share	2.84	2.82	3.00	3.25	3.85	3.25	2.22	3.67	4.31	4.48
FCF Conversion (FCF/Net Income)	1.29x	1.51x	1.27x	1.32x	1.38x	1.54x	1.43x	1.63x	1.42x	1.97x
Interest Paid	162M	150M	194M	185M	188M	194M	151M	280M	302M	0
Taxes Paid	932M	1.04B	847M	803M	845M	890M	945M	937M	933M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	14358.82%	1556.92%	1090.91%	627.02%	324.89%	209.07%	200.9%	260.92%	384.94%	469.09%
Return on Invested Capital (ROIC)	55.16%	57.16%	51.92%	40.32%	35.37%	35.54%	31.13%	33.76%	38.64%	43.41%
Gross Margin	60.1%	60.33%	59.23%	59.12%	60.31%	59.08%	56.49%	57.82%	60.23%	60.11%
Net Margin	16.06%	13.1%	15.44%	15.08%	16.36%	12.43%	9.93%	11.82%	14.37%	10.46%
Debt / Equity	384.29x	27.07x	32.31x	15.20x	7.46x	8.07x	11.50x	9.47x	15.65x	21.88x
Interest Coverage	26.58x	26.20x	19.95x	19.59x	24.44x	33.21x	21.47x	14.39x	15.01x	16.28x
FCF Conversion	1.29x	1.51x	1.27x	1.32x	1.38x	1.54x	1.43x	1.63x	1.42x	1.97x
Revenue Growth	-5.23%	1.7%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%	1.4%

US Stock Screener

...

Colgate-Palmolive Company (CL) 10-Year Financial Performance & Capital Metrics

CL •

Consumer DefensiveHousehold ProductsPersonal Care and Beauty Products

Revenue $20.38B +1.4%
EBITDA $4.98B -0.2%
Net Income $2.13B -26.2%
EPS (Diluted) 2.63 -25.1%
Gross Margin 60.11% -0.2%
EBITDA Margin 24.42% -1.6%
Operating Margin 21.33% -2.2%
Net Margin 10.46% -27.2%
ROE 469.09% +21.9%
ROIC 43.41% +12.3%
Debt/Equity 21.88 +39.9%
Interest Coverage 16.28 +8.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 371.6%
✓FCF machine: 17.8% free cash flow margin
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 2.3%
✓Healthy 5Y average net margin of 11.8%
✓Trading near 52-week high

✗Weaknesses

✗High debt to equity ratio of 21.9x
✗Expensive at 220.3x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.43%

5Y4.35%

3Y4.29%

TTM1.4%

Profit (Net Income) CAGR

10Y4.42%

5Y-4.58%

3Y6.1%

TTM-26.26%

EPS CAGR

10Y5.64%

5Y-3.48%

3Y7.28%

TTM-25.45%

ROCE

10Y Avg38.86%

5Y Avg36.61%

3Y Avg38.98%

Latest41.65%

Peer Comparison

Personal Care and Beauty Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
DSYBig Tree Cloud Holdings Limited	178.66M	3.13	254.47	16.37%	-4.42%	2.43%
AXILAXIL Brands, Inc.	46.22M	6.80	67.95	-4.51%	4.95%	12.37%	3.32%	0.08
ELFe.l.f. Beauty, Inc.	5.13B	92.05	47.94	28.28%	6.84%	8.95%	2.25%	0.41
EPCEdgewell Personal Care Company	1.06B	22.74	42.91	-1.34%	-1.76%	-2.57%	3.9%	0.99
CLColgate-Palmolive Company	79.91B	99.14	37.70	1.4%	10.46%	5.84%	4.55%	21.88
IPARInter Parfums, Inc.	3.23B	100.78	19.68	10.22%	11.24%	14.9%	5.66%	0.20
SLSNSolesence, Inc. Common Stock	90.29M	1.28	18.29	40.35%	1.72%	6.21%		1.02
COTYCoty Inc.	2.19B	2.51	-5.70	-3.68%	-9.19%	-14.39%	12.68%	1.07

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	15.2B	15.45B	15.54B	15.69B	16.47B	17.42B	17.97B	19.46B	20.1B	20.38B
Revenue Growth %	-5.23%	1.7%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%	1.4%
Cost of Goods Sold+	6.06B	6.13B	6.34B	6.42B	6.54B	7.13B	7.82B	8.21B	8B	8.13B
COGS % of Revenue	39.9%	39.67%	40.77%	40.88%	39.69%	40.92%	43.51%	42.18%	39.77%	39.89%
Gross Profit+	9.13B	9.32B	9.21B	9.28B	9.93B	10.29B	10.15B	11.25B	12.11B	12.25B
Gross Margin %	60.1%	60.33%	59.23%	59.12%	60.31%	59.08%	56.49%	57.82%	60.23%	60.11%
Gross Profit Growth %	-2.54%	2.09%	-1.26%	0.77%	7.07%	3.62%	-1.39%	10.85%	7.6%	1.2%
Operating Expenses+	5.17B	5.31B	5.36B	5.51B	6.02B	6.41B	6.57B	7.12B	7.72B	7.9B
OpEx % of Revenue	34.04%	34.39%	34.46%	35.14%	36.56%	36.78%	36.54%	36.59%	38.42%	38.77%
Selling, General & Admin	4.88B	5.03B	5.08B	5.23B	5.73B	6.1B	6.25B	6.78B	7.81B	7.9B
SG&A % of Revenue	32.14%	32.54%	32.67%	33.35%	34.8%	35.02%	34.76%	34.83%	38.85%	38.77%
Research & Development	289M	285M	277M	281M	290M	307M	320M	343M	355M	0
R&D % of Revenue	1.9%	1.84%	1.78%	1.79%	1.76%	1.76%	1.78%	1.76%	1.77%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	-442M	0
Operating Income+	3.96B	4.01B	3.85B	3.76B	3.91B	3.89B	3.58B	4.13B	4.38B	4.35B
Operating Margin %	26.06%	25.94%	24.77%	23.97%	23.74%	22.31%	19.95%	21.23%	21.8%	21.33%
Operating Income Growth %	-0.25%	1.24%	-3.97%	-2.29%	3.96%	-0.64%	-7.75%	15.23%	6.1%	-0.8%
EBITDA+	4.4B	4.48B	4.36B	4.28B	4.45B	4.44B	4.13B	4.7B	4.99B	4.98B
EBITDA Margin %	28.98%	29.02%	28.06%	27.28%	27.02%	25.5%	22.99%	24.15%	24.81%	24.42%
EBITDA Growth %	-0.36%	1.84%	-2.74%	-1.83%	3.95%	-0.18%	-7.02%	13.75%	6.17%	-0.2%
D&A (Non-Cash Add-back)	443M	475M	511M	519M	539M	556M	545M	567M	605M	630M
EBIT	3.89B	3.64B	3.66B	3.49B	3.81B	3.2B	2.83B	3.68B	4.25B	3.33B
Net Interest Income+	-99M	-102M	-143M	-145M	-141M	-100M	-153M	-232M	-225M	-192M
Interest Income	50M	51M	50M	47M	19M	17M	14M	55M	67M	75M
Interest Expense	149M	153M	193M	192M	160M	117M	167M	287M	292M	267M
Other Income/Expense	-222M	-522M	-386M	-461M	-264M	-799M	-925M	-739M	-427M	-1.29B
Pretax Income+	3.74B	3.49B	3.46B	3.3B	3.65B	3.09B	2.66B	3.39B	3.96B	3.06B
Pretax Margin %	24.6%	22.56%	22.29%	21.03%	22.14%	17.72%	14.8%	17.43%	19.68%	15.01%
Income Tax+	1.15B	1.31B	906M	774M	787M	749M	693M	937M	907M	798M
Effective Tax Rate %	65.3%	58.04%	69.28%	71.71%	73.9%	70.17%	67.11%	67.81%	73.03%	69.7%
Net Income+	2.44B	2.02B	2.4B	2.37B	2.69B	2.17B	1.78B	2.3B	2.89B	2.13B
Net Margin %	16.06%	13.1%	15.44%	15.08%	16.36%	12.43%	9.93%	11.82%	14.37%	10.46%
Net Income Growth %	76.37%	-17.08%	18.58%	-1.38%	13.86%	-19.63%	-17.59%	28.85%	25.61%	-26.2%
Net Income (Continuing)	2.59B	2.17B	2.56B	2.53B	2.86B	2.34B	1.97B	2.46B	3.05B	2.26B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	260M	303M	299M	441M	358M	362M	405M	348M	332M	311M
EPS (Diluted)+	2.72	2.28	2.75	2.75	3.14	2.55	2.13	2.77	3.51	2.63
EPS Growth %	78.95%	-16.18%	20.61%	0%	14.18%	-18.79%	-16.47%	30.05%	26.71%	-25.07%
EPS (Basic)	2.74	2.30	2.76	2.76	3.15	2.56	2.13	2.78	3.53	2.64
Diluted Shares Outstanding	898.4M	887.8M	873M	861.1M	859.3M	848.3M	838.8M	829.2M	822.5M	811.1M
Basic Shares Outstanding	891.8M	881.8M	870.6M	859.1M	856.8M	845M	836.4M	827.4M	817.7M	808.7M
Dividend Payout Ratio	61.78%	75.54%	66.29%	68.19%	55.73%	77.52%	94.73%	76.04%	61.92%	85.51%

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	4.34B	4.64B	3.79B	4.18B	4.34B	4.4B	5.11B	5.28B	5.32B	5.71B
Cash & Short-Term Investments	1.31B	1.53B	726M	883M	888M	832M	775M	966M	1.26B	1.29B
Cash Only	1.31B	1.53B	726M	883M	888M	832M	775M	966M	1.1B	1.29B
Short-Term Investments	0	0	0	0	0	0	0	0	160M	0
Accounts Receivable	1.41B	1.48B	1.4B	1.44B	1.26B	1.3B	1.5B	1.59B	1.52B	1.68B
Days Sales Outstanding	33.89	34.96	32.87	33.49	28.01	27.17	30.55	29.75	27.62	30
Inventory	1.17B	1.22B	1.25B	1.4B	1.67B	1.69B	2.07B	1.93B	1.99B	2.03B
Days Inventory Outstanding	70.5	72.69	71.99	79.64	93.4	86.64	96.84	86.02	90.71	91.22
Other Current Assets	441M	403M	417M	456M	513M	576M	760M	793M	553M	714M
Total Non-Current Assets+	7.79B	8.04B	8.37B	10.86B	11.58B	10.64B	10.62B	11.11B	10.73B	10.62B
Property, Plant & Equipment	3.84B	4.07B	3.88B	3.75B	3.72B	3.73B	4.31B	4.58B	4.42B	4.66B
Fixed Asset Turnover	3.96x	3.80x	4.01x	4.18x	4.43x	4.67x	4.17x	4.25x	4.55x	4.37x
Goodwill	2.11B	2.22B	2.53B	3.51B	3.82B	3.28B	3.35B	3.41B	3.27B	3.12B
Intangible Assets	1.31B	1.34B	1.64B	2.67B	2.89B	2.46B	1.92B	1.89B	1.76B	1.54B
Long-Term Investments	0	0	0	0	0	0	0	0	81M	0
Other Non-Current Assets	224M	218M	168M	753M	857M	974M	904M	1.02B	1B	1.3B
Total Assets+	12.12B	12.68B	12.16B	15.03B	15.92B	15.04B	15.73B	16.39B	16.05B	16.33B
Asset Turnover	1.25x	1.22x	1.28x	1.04x	1.03x	1.16x	1.14x	1.19x	1.25x	1.25x
Asset Growth %	1.38%	4.56%	-4.06%	23.62%	5.89%	-5.53%	4.59%	4.21%	-2.12%	1.77%
Total Current Liabilities+	3.31B	3.41B	3.34B	4.04B	4.4B	4.05B	4B	4.74B	5.76B	5.74B
Accounts Payable	1.12B	1.21B	1.22B	1.24B	1.39B	1.48B	1.55B	1.7B	1.8B	0
Days Payables Outstanding	67.67	72.15	70.37	70.37	77.77	75.73	72.42	75.53	82.4	-
Short-Term Debt	13M	11M	12M	514M	267M	51M	25M	330M	660M	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	84M	101M	93M	70M	182M	93M	97M	122M	116M	5.74B
Current Ratio	1.31x	1.36x	1.14x	1.03x	0.99x	1.09x	1.28x	1.11x	0.92x	1.00x
Quick Ratio	0.96x	1.00x	0.76x	0.69x	0.61x	0.67x	0.76x	0.71x	0.58x	0.64x
Cash Conversion Cycle	36.72	35.49	34.49	42.77	43.64	38.08	54.97	40.25	35.93	-
Total Non-Current Liabilities+	8.8B	9.03B	8.62B	10.44B	10.41B	10.02B	10.92B	10.7B	9.74B	10.23B
Long-Term Debt	6.52B	6.57B	6.35B	7.33B	7.33B	7.19B	8.74B	8.22B	7.29B	7.99B
Capital Lease Obligations	0	0	0	491M	476M	451M	397M	420M	456M	0
Deferred Tax Liabilities	246M	204M	235M	507M	426M	395M	383M	361M	343M	0
Other Non-Current Liabilities	2.04B	2.25B	2.03B	2.11B	2.18B	1.98B	1.4B	1.7B	1.66B	2.24B
Total Liabilities	12.11B	12.43B	11.96B	14.48B	14.82B	14.07B	14.93B	15.44B	15.5B	15.96B
Total Debt+	6.53B	6.58B	6.37B	8.48B	8.21B	7.83B	9.27B	9.06B	8.51B	7.99B
Net Debt	5.22B	5.04B	5.64B	7.6B	7.33B	7B	8.5B	8.1B	7.42B	6.7B
Debt / Equity	384.29x	27.07x	32.31x	15.20x	7.46x	8.07x	11.50x	9.47x	15.65x	21.88x
Debt / EBITDA	1.48x	1.47x	1.46x	1.98x	1.85x	1.76x	2.24x	1.93x	1.71x	1.60x
Net Debt / EBITDA	1.19x	1.12x	1.29x	1.78x	1.65x	1.58x	2.06x	1.72x	1.49x	1.35x
Interest Coverage	26.58x	26.20x	19.95x	19.59x	24.44x	33.21x	21.47x	14.39x	15.01x	16.28x
Total Equity+	17M	243M	197M	558M	1.1B	971M	806M	957M	544M	365M
Equity Growth %	138.64%	1329.41%	-18.93%	183.25%	97.31%	-11.81%	-16.99%	18.73%	-43.16%	-32.9%
Book Value per Share	0.02	0.27	0.23	0.65	1.28	1.14	0.96	1.15	0.66	0.45
Total Shareholders' Equity	-243M	-60M	-102M	117M	743M	609M	401M	609M	212M	54M
Common Stock	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	1.47B	0
Retained Earnings	19.92B	20.53B	21.61B	22.5B	23.7B	24.35B	24.57B	25.29B	26.14B	0
Treasury Stock	-19.14B	-20.18B	-21.2B	-22.06B	-23.05B	-24.09B	-25.13B	-26.02B	-27.36B	0
Accumulated OCI	-4.18B	-3.85B	-4.19B	-4.27B	-4.34B	-4.39B	-4.05B	-3.94B	-4.22B	0
Minority Interest	260M	303M	299M	441M	358M	362M	405M	348M	332M	311M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	3.14B	3.05B	3.06B	3.13B	3.72B	3.33B	2.56B	3.75B	4.11B	4.2B
Operating CF Margin %	20.67%	19.76%	19.66%	19.96%	22.58%	19.09%	14.23%	19.25%	20.43%	20.6%
Operating CF Growth %	6.51%	-2.77%	0.07%	2.52%	18.7%	-10.59%	-23.13%	46.52%	9.67%	2.22%
Net Income	2.59B	2.17B	2.56B	2.53B	2.86B	2.34B	1.97B	2.46B	3.05B	2.13B
Depreciation & Amortization	443M	475M	511M	519M	539M	556M	545M	567M	605M	630M
Stock-Based Compensation	123M	127M	109M	100M	107M	135M	125M	122M	135M	0
Deferred Taxes	56M	383M	107M	17M	-120M	-132M	-78M	-98M	-77M	-109M
Other Non-Cash Items	-159M	10M	-74M	-95M	-48M	625M	723M	244M	51M	1.26B
Working Capital Changes	92M	-115M	-155M	65M	381M	-197M	-726M	455M	344M	284M
Change in Receivables	-17M	-15M	-79M	19M	138M	-84M	-227M	-37M	-56M	-16M
Change in Inventory	-4M	-8M	-58M	-77M	-251M	-72M	-333M	194M	-100M	109M
Change in Payables	0	0	0	0	0	0	0	0	516M	251M
Cash from Investing+	-499M	-471M	-1.17B	-2.1B	-878M	-592M	-1.6B	-742M	-534M	-817M
Capital Expenditures	-593M	-553M	-436M	-335M	-410M	-567M	-696M	-705M	-561M	-564M
CapEx % of Revenue	3.9%	3.58%	2.8%	2.13%	2.49%	3.25%	3.87%	3.62%	2.79%	2.77%
Acquisitions	-5M	0	-728M	-1.71B	-452M	0	-809M	0	0	-293M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	57M	38M	7M	0	3M	-25M	52M	-33M	37M	-14M
Cash from Financing+	-2.23B	-2.45B	-2.68B	-870M	-2.82B	-2.77B	-952M	-2.79B	-3.39B	-3.26B
Debt Issued (Net)	164M	-29M	-179M	1.43B	-564M	-175M	1.65B	-314M	-408M	-456M
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Dividends Paid	-1.51B	-1.53B	-1.59B	-1.61B	-1.5B	-1.68B	-1.69B	-1.75B	-1.79B	-1.82B
Share Repurchases	-1.33B	-1.4B	-1.24B	-1.2B	-1.48B	-1.32B	-1.31B	-1.13B	-1.74B	-1.21B
Other Financing	446M	507M	329M	513M	-152M	400M	400M	398M	547M	132M
Net Change in Cash	345M	220M	-809M	157M	5M	-56M	-57M	191M	130M	192M
Free Cash Flow+	2.55B	2.5B	2.62B	2.8B	3.31B	2.76B	1.86B	3.04B	3.55B	3.63B
FCF Margin %	16.77%	16.18%	16.86%	17.83%	20.09%	15.83%	10.35%	15.62%	17.64%	17.83%
FCF Growth %	12.84%	-1.84%	4.76%	6.79%	18.26%	-16.65%	-32.56%	63.44%	16.64%	2.48%
FCF per Share	2.84	2.82	3.00	3.25	3.85	3.25	2.22	3.67	4.31	4.48
FCF Conversion (FCF/Net Income)	1.29x	1.51x	1.27x	1.32x	1.38x	1.54x	1.43x	1.63x	1.42x	1.97x
Interest Paid	162M	150M	194M	185M	188M	194M	151M	280M	302M	0
Taxes Paid	932M	1.04B	847M	803M	845M	890M	945M	937M	933M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	14358.82%	1556.92%	1090.91%	627.02%	324.89%	209.07%	200.9%	260.92%	384.94%	469.09%
Return on Invested Capital (ROIC)	55.16%	57.16%	51.92%	40.32%	35.37%	35.54%	31.13%	33.76%	38.64%	43.41%
Gross Margin	60.1%	60.33%	59.23%	59.12%	60.31%	59.08%	56.49%	57.82%	60.23%	60.11%
Net Margin	16.06%	13.1%	15.44%	15.08%	16.36%	12.43%	9.93%	11.82%	14.37%	10.46%
Debt / Equity	384.29x	27.07x	32.31x	15.20x	7.46x	8.07x	11.50x	9.47x	15.65x	21.88x
Interest Coverage	26.58x	26.20x	19.95x	19.59x	24.44x	33.21x	21.47x	14.39x	15.01x	16.28x
FCF Conversion	1.29x	1.51x	1.27x	1.32x	1.38x	1.54x	1.43x	1.63x	1.42x	1.97x
Revenue Growth	-5.23%	1.7%	0.58%	0.96%	4.96%	5.77%	3.13%	8.29%	3.31%	1.4%

Colgate-Palmolive Company (CL) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare CL vs Peers

vs EL

vs ELF

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Colgate-Palmolive Company (CL) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare CL vs Peers

vs EL

vs ELF

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios